| Document |
Document Title |
|
WO/2022/182844A1 |
The invention is directed to processes for purifying cannabinoids from fermentates, such as a yeast fermentate.
|
|
WO/2022/171887A1 |
The present invention relates to compounds of the following formula (I), where: - X is OH, SH or a thio(C1-C6)alkyl group ; - R' is H, OH or -Ra, Ra representing a (C1-C12)alkyl group; - R'' is H, Rb, -ORb, -COOH, -COORb, or -CORb, Rb re...
|
|
WO/2022/160056A1 |
DMT nicotinate and DMT pamoate are disclosed. DMT and its salts are found useful in the treatment of stroke, multiple sclerosis, Parkinson's disease, and traumatic brain injury. They are particularly useful in the treatment of haemorrhag...
|
|
WO/2022/149532A1 |
Provided are a lignin-degrading catalyst that has exceptional properties for degrading lignin and that readily isolates lignin after a degradation reaction, a method for manufacturing the lignin-degrading catalyst, and a method for degra...
|
|
WO/2022/133587A1 |
The present invention relates to antimicrobial compositions comprising graphene-silver cation nanocomposites and uses for same as a broad-spectrum antimicrobial agent, and uses for same for treating microbial infections, including infect...
|
|
WO/2022/126888A1 |
The present invention provides a compound having a pancreatic islet protection function, and a preparation method therefor and an application thereof. The structural formula (I) of the compound is shown as follows. The present invention ...
|
|
WO/2022/121317A1 |
Disclosed is a 1,1'-biphenyl-2,6-diphenolic compound and the use thereof. The 1,1'-biphenyl-2,6-diphenolic compound is a new compound, and has good biological activity. By means of in vitro tumor cell activity experiments, it was found t...
|
|
WO/2022/115973A1 |
Disclosed are methods for precipitation of CBDA-amine salts and THCA-amine salts from concentrated crude complex extracts. The crude complex extracts may be recovered from cannabis biomass or fermentation systems wherein microorganisms w...
|
|
WO/2022/113814A1 |
Provided are: a radiation-sensitive resin composition able to exhibit satisfactory levels of sensitivity, LWR performance and CDU performance; a method for forming a pattern; and an onium salt compound. This radiation-sensitive resin com...
|
|
WO/2022/108071A1 |
The present invention relates to a method for purifying bis-2-hydroxylethyl terephthalate and to providing polyester resin comprising same.
|
|
WO/2022/091141A1 |
The present invention relates to a process for preparation of 2-((1-benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro
-1H-inden-1-one Hydrochloride (Donepezil hydrochloride) of formula I. The present invention also relates to a inte...
|
|
WO/2022/091731A1 |
The present invention provides a resist material that can be used in radiation lithography and is capable of forming fine patterns while maintaining high sensitivity. Specifically, the present invention provides a metal complex character...
|
|
WO/2022/090533A1 |
The invention relates to cocrystals comprising a substituted 2-oxo-l- pyrrolidinyl triazole of formula (I) and a carboxylic acid of formula (II).
|
|
WO/2022/067064A1 |
The present invention relates to methods for treating cannabis biomass in order to isolate tetrahydrocannabinolic acid (THCA). In another aspect, the present invention relates to a process that involves purification followed by extractio...
|
|
WO/2022/047574A1 |
The present disclosure relates to a method for producing a purified cannabinoid extract comprising mixing a cannabaceae biomass extract comprising cannabinoid compounds in methanol to obtain a substantially homogeneous methanolic phase; ...
|
|
WO/2022/038098A1 |
The present invention relates to a process for the preparation of phenyl ketones and the preparation of phenoxyphenyl derivatives.
|
|
WO/2022/031773A1 |
The present disclosure encompasses solid state forms of Fezolinetant, including salts and cocrystals of Fezolinetant, in embodiments crystalline polymorphs of Fezolinetant, processes for preparation thereof, and pharmaceutical compositio...
|
|
WO/2022/016254A1 |
The present disclosure relates generally to methods and cells for the production of substituted phytocannabinoids or substituted phytocannabinoid precursors in host cells that produce the phytocannabinoid or the phytocannabinoid precurso...
|
|
WO/2022/016288A1 |
Disclosed herein are cannabinoid salt compounds formed by mixing an acidic cannabinoid compound with a base. According to embodiments of the present disclosure, the base is selected at least for having a low toxicity. Also disclosed are ...
|
|
WO/2022/016269A1 |
Pharmaceutical formulations and treatments are provided that make combined use of selected antibiotic cannabinoids with silver-containing medicaments. Therapeutically effective regimens are provided that facilitate positive drug-drug int...
|
|
WO/2021/252295A1 |
A process of making Roxadustat of the following formula (I): comprising converting a compound of formula (VI): to Roxadustat, wherein R is a C1-C20 alkyl group, and PG is a protective group.
|
|
WO/2021/245676A1 |
The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
|
|
WO/2021/245672A1 |
The present invention provides novel compounds comprising cannabigerlic acid (CBGA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
|
|
WO/2021/245671A1 |
The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
|
|
WO/2021/245675A1 |
The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
|
|
WO/2021/228082A1 |
A porous polymer-sulfur composite material and a preparation method therefor and use thereof. The porous polymer is obtained by the reaction of aldehyde and amine monomers, and sulfur dissolved in a solvent is poured into the porous poly...
|
|
WO/2021/226711A1 |
Disclosed are methods for preparing carmabigerol (CBG) or a CBG analog, embodiments of the method comprising providing a compound (I); combining the compound (I) with geraniol and a solvent to form a reaction mixture; and combining the r...
|
|
WO/2021/217241A1 |
The present disclosure relates to a method for producing a purified cannabaceae biomass extract, wherein a crude alcoholic cannabaceae biomass extract comprising at least two cannabinoid compounds in an alcoholic solvent is circulating t...
|
|
WO/2021/220512A1 |
Provided is a compound represented by formula (1). (In the formula, R1 represents a hydrogen atom or a methyl group, X1 represents a C1-C9 alkylene group, and a C3-C6 alkylene group in which at least one hydrogen is substituted with an a...
|
|
WO/2021/215900A1 |
The present invention provides a method for producing 2-(2,5-difluorophenyl)-3-carboxy-7-chloro-(4H)-4-benzopyrano
ne represented by chemical formula 1, a novel intermediate used therein, and a method for producing same. Specifically, an...
|
|
WO/2021/209473A1 |
The invention relates to a compound of formula (I) wherein R1-R3 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
|
|
WO/2021/193565A1 |
In a preferred embodiment, this production method for a cyclic compound or a derivative thereof has: a drying step for subjecting a feedstock liquid containing the cyclic compound or the derivative thereof to a drying treatment to obtain...
|
|
WO/2021/160139A1 |
A 9,10-dihydrophenanthrene compound and use thereof in the treatment of liver injury. Specifically, a compound of formula (I) or a compound of formula (II) is provided, which exhibits anti-inflammatory and antioxidant activities in liver...
|
|
WO/2021/155081A1 |
Alkyl salicylic acids, overbased detergents derived from alkyl salicylic acids, lubricating compositions including the alkyl salicylic acids and/or overbased detergents, and processes of making and using the same, are described.
|
|
WO/2021/151198A1 |
The present disclosure relates to a method for preventing or reducing cannabaceae biomass decomposition during storage by packaging an amount of the biomass in a flexible film of gas impervious material to provide a cannabaceae biomass p...
|
|
WO/2021/131538A1 |
Provided are: a chemically amplified positive photosensitive resin composition that readily forms a resist pattern having a rectangular cross-sectional shape, the composition having excellent sensitivity and being capable of suppressing ...
|
|
WO/2021/129651A1 |
Disclosed is a novel 2-[4-[(E)-(2-ketocyclohexenyl)methyl]phenyl]propionic acid crystal, filling the vacancy of crystal form disclosures at present. In addition, the present crystal form is less likely to absorb moisture and is stable un...
|
|
WO/2021/127743A1 |
The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.
|
|
WO/2021/101867A1 |
The disclosure provides salts of (2R,6R)-hydroxynorketamine (HNK), wherein the salt is with an organic acid chosen from malonic acid, salicylic acid, ethane sulfonic acid, glycolic acid, stearic acid, or capric acid, and their crystal fo...
|
|
WO/2021/081640A1 |
Disclosed herein is a high-effective-concentration cannabinoid-based vape oil that is flowable within a vape device. The high-effective-concentration cannabinoid-based vape oil comprises a cannabinoid-based incipient and a cannabinoid-ba...
|
|
WO/2021/065350A1 |
Provided are: a radiation-sensitive resin composition having excellent performance in terms of sensitivity, LWR, etc., in an exposure step even when a next-generation exposure technique is applied; and a method for forming a resist patte...
|
|
WO/2021/052353A1 |
The present invention relates to the technical field of enzyme inhibitors, and relates in particular to a hydroxamic acid derivative, a preparation method therefor and an application thereof. The hydroxamic acid group in the hydroxamic a...
|
|
WO/2021/016720A1 |
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...
|
|
WO/2021/012046A1 |
There are provided compositions comprising at least one compound chosenfrom compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV) and a cannabinoid extract.
|
|
WO/2021/001044A1 |
Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of Eltrombopag, passing through/using intermediate 5'-Chloro-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid alkaline metal sal...
|
|
WO/2021/000053A1 |
The present invention provides cannabinoid derivatives, a pharmaceutical composition comprising said derivative and a method of using said derivatives in treating or preventing a disease associated with cannabinoid receptors. The claimed...
|
|
WO/2020/263229A1 |
The present invention provides a composition comprising an acidic formulation containing β-hydroxy-β-methylbutyrate (HMB), preferably in the free acid form, Vitamin D and a stabilizing excipient, wherein the Vitamin D is stabilized aga...
|
|
WO/2020/262452A1 |
The present invention addresses the problem of providing a novel hydrogen storage material containing a metal organic structure capable of effectively storing hydrogen. Hydrogen can be effectively stored using a hydrogen storage materi...
|
|
WO/2020/262451A1 |
The invention addresses the problem that metal-organic frameworks have conventionally only been produced with terephthalic acids having a limited range of substituents even though the amount and type of gas stored thereby can vary depend...
|
|
WO/2020/253076A1 |
Discloses the use of a hydroxycarboxylic acid compound for controlling plant diseases by fungi and oomycetes, wherein the hydroxycarboxylic acid compound is selected from compounds of formulas (I), (II), (III) and (IV), as well as isomer...
|
